Two Sigma Securities’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-48,500
| Closed | -$2.74M | – | 1502 |
|
|
2024
Q4 | $2.74M | Sell |
48,500
-165,600
| -77% | -$9.25M | 0.36% | 32 |
|
|
2024
Q3 | $11.1M | Sell |
214,100
-218,700
| -51% | -$10.3M | 0.19% | 138 |
|
|
2024
Q2 | $18M | Buy |
432,800
+155,400
| +56% | +$6.95M | 0.22% | 88 |
|
|
2024
Q1 | $15M | Buy |
277,400
+18,800
| +7% | +$958K | 0.15% | 164 |
|
|
2023
Q4 | $13.3M | Sell |
258,600
-180,400
| -41% | -$9.47M | 0.13% | 169 |
|
|
2023
Q3 | $25.5M | Buy |
439,000
+379,100
| +633% | +$23.2M | 0.27% | 65 |
|
|
2023
Q2 | $3.83M | Sell |
59,900
-11,500
| -16% | -$771K | 0.06% | 373 |
|
|
2023
Q1 | $4.95M | Buy |
71,400
+4,300
| +6% | +$303K | 0.1% | 240 |
|
|
2022
Q4 | $4.83M | Buy |
67,100
+41,900
| +166% | +$3.16M | 0.14% | 155 |
|
|
2022
Q3 | $1.79M | Sell |
25,200
-123,800
| -83% | -$8.98M | 0.05% | 398 |
|
|
2022
Q2 | $11.5M | Buy |
149,000
+89,700
| +151% | +$6.83M | 0.41% | 41 |
|
|
2022
Q1 | $4.33M | Buy |
59,300
+51,800
| +691% | +$3.48M | 0.15% | 151 |
|
|
2021
Q4 | $468K | Buy |
7,500
+3,600
| +92% | +$211K | 0.02% | 559 |
|
|
2021
Q3 | $231K | Sell |
3,900
-63,500
| -94% | -$4.18M | 0.01% | 1161 |
|
|
2021
Q2 | $4.5M | Buy |
+67,400
| New | +$4.39M | 0.14% | 96 |
|
|
2021
Q1 | – | Sell |
-27,900
| Closed | -$1.73M | – | 920 |
|
|
2020
Q4 | $1.73M | Buy |
27,900
+1,000
| +4% | +$61.5K | 0.04% | 266 |
|
|
2020
Q3 | $1.62M | Buy |
26,900
+1,000
| +4% | +$60.2K | 0.03% | 249 |
|
|
2020
Q2 | $1.52M | Sell |
25,900
-23,200
| -47% | -$1.39M | 0.03% | 290 |
|
|
2020
Q1 | $2.74M | Sell |
49,100
-169,200
| -78% | -$10.3M | 0.06% | 199 |
|
|
2019
Q4 | $14M | Buy |
218,300
+57,200
| +36% | +$3.28M | 0.09% | 150 |
|
|
2019
Q3 | $8.17M | Sell |
161,100
-51,200
| -24% | -$2.41M | 0.07% | 199 |
|
|
2019
Q2 | $9.63M | Buy |
+212,300
| New | +$9.89M | 0.1% | 116 |
|
|
2019
Q1 | – | Sell |
-24,100
| Closed | -$1.25M | – | 1847 |
|
|
2018
Q4 | $1.25M | Sell |
24,100
-93,500
| -80% | -$5.02M | 0.02% | 544 |
|
|
2018
Q3 | $7.3M | Sell |
117,600
-154,500
| -57% | -$9.17M | 0.05% | 282 |
|
|
2018
Q2 | $15.1M | Buy |
272,100
+88,200
| +48% | +$4.76M | 0.08% | 200 |
|
|
2018
Q1 | $11.6M | Buy |
183,900
+170,700
| +1,293% | +$11M | 0.07% | 253 |
|
|
2017
Q4 | $809K | Buy |
+13,200
| New | +$826K | 0.02% | 494 |
|
Other funds holding BMY
Two Sigma Securities's BMY Position: Q4 2025 in Review
Two Sigma Securities sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 43,983 shares — an estimated $1.98M sold.
Two Sigma Securities first reported a position in BMY in Q4 2016 and held it in 28 quarters. The position peaked at $18.8M in Q3 2023. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Two Sigma Securities reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- Two Sigma Securities sold 43,983 Bristol-Myers Squibb shares in Q4 2025, an estimated $1.98M.
- Two Sigma Securities first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 28 quarters.
- Two Sigma Securities's Bristol-Myers Squibb position peaked at $18.8M in Q3 2023.
- 2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.